Knoa Pharma appoints Michael Goettler as president and CEO effective July 6

The pharmaceutical company, which began operations on May 1, 2026, said the former Viatris CEO will also join its board as its fifth member.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.